Fig. 1
From: Classifications of triple-negative breast cancer: insights and current therapeutic approaches
Consensus guidelines for TNBC treatment. This figure illustrates the biomarker-driven approaches for managing mTNBC as outlined in various clinical practice guidelines. It emphasizes the role of PD-L1 expression and gBRCA mutations as critical predictive biomarkers, reflecting a shared consensus among leading guidelines in optimizing treatment strategies for mTNBC